Histogen Inc (HSTO)
0.50
0.00 (0.00%)
USD |
OTCM |
Apr 18, 16:00
Histogen Total Liabilities (Quarterly): 1.413M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.413M |
| June 30, 2023 | 5.277M |
| March 31, 2023 | 5.729M |
| December 31, 2022 | 5.697M |
| September 30, 2022 | 5.933M |
| June 30, 2022 | 5.739M |
| March 31, 2022 | 11.84M |
| December 31, 2021 | 7.059M |
| Date | Value |
|---|---|
| September 30, 2021 | 7.288M |
| June 30, 2021 | 6.841M |
| March 31, 2021 | 7.182M |
| December 31, 2020 | 8.10M |
| September 30, 2020 | 7.44M |
| June 30, 2020 | 9.46M |
| December 31, 2019 | 40.91M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.413M
Minimum
Sep 2023
40.91M
Maximum
Dec 2019
9.060M
Average
7.059M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Protalix BioTherapeutics Inc | 50.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.817M |
| Shareholders Equity (Quarterly) | 5.436M |
| Current Ratio | 4.047 |